On Nov 20, major Wall Street analysts update their ratings for $Medtronic (MDT.US)$, with price targets ranging from $90 to $105.
Morgan Stanley analyst Patrick Wood maintains with a buy rating, and maintains the target price at $98.
BofA Securities analyst Travis Steed maintains with a buy rating, and sets the target price at $100.
Citi analyst Joanne Wuensch maintains with a hold rating, and maintains the target price at $92.
Barclays analyst Matt Miksic maintains with a buy rating, and maintains the target price at $105.
UBS analyst Danielle Antalffy maintains with a hold rating, and adjusts the target price from $90 to $93.
Furthermore, according to the comprehensive report, the opinions of $Medtronic (MDT.US)$'s main analysts recently are as follows:
Although maintaining a positive outlook for the FY25 high single-digit EPS growth rate as an indicator for future performance, analysts note the company will face challenges into FY26 with ongoing FX pressures, dilutive effects from new products and capital rollouts, and slight tax headwinds, which may impede a steady return to high single-digit EPS growth.
Medtronic's Q2 revenue outperformed expectations largely due to strong performance in the cardiovascular, neuro, and diabetes sectors. Furthermore, the company has increased its FY25 growth projections to between 4.75%-5.0%. Analysts maintain a positive outlook into FY26, anticipating that earnings growth may surpass overall revenue growth.
Here are the latest investment ratings and price targets for $Medtronic (MDT.US)$ from 11 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
